Results 121 to 130 of about 12,768 (245)

Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.

open access: yes, 2012
BACKGROUND: Treatment options for drug-resistant tuberculosis (DR-TB) are limited. Linezolid has been successfully used to treat DR-TB in adults, but there are few case reports of its use in children for TB.
Hallbauer, UM   +4 more
core   +1 more source

KatG protein analysis: Misfolding and drug resistance

open access: yes
Tuberculosis is caused by Mycobacterium tuberculosis and is commonly treated with antibiotics. Recently, drug resistance to isoniazid, the most common drug utilized to treat tuberculosis, has been becoming more prevalent. Hence, this study aimed to analyze factors affecting isoniazid resistance using a bioinformatics pipeline.
Daniel Ryan Fugaha   +4 more
openaire   +1 more source

Prevalence of katG and inhA mutations associated with isoniazid resistance in Mycobacterium tuberculosis clinical isolates in Cameroon

open access: yesBMC Microbiology
Background The acquisition of isoniazid (INH) resistance is alarming, considering its importance as a key drug that forms the core of multidrug treatment regimens for tuberculosis (TB). Genetic mutations in the katG and inhA promoter regions play crucial
Vanessa Ninkeh Nono   +13 more
doaj   +1 more source

KatG as Counterselection Marker for Nontuberculous Mycobacteria

open access: yesAntimicrobial Agents and Chemotherapy, 2020
Gagliardi, Aron   +5 more
openaire   +4 more sources

Regulation of catalase–peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis [PDF]

open access: bronze, 2001
Alexander S. Pym   +5 more
openalex   +1 more source

The Susceptibility of katG Ser315Thr Mycobacterium tuberculosis mutant Against Anti Tuberculosis Drugs

open access: yesIndonesian Journal of Biotechnology, 2016
Mycobacterium tuberculosis resistant strains is a matter of great concern for TB control Program since nocure for some multi drug resistance TB (MDR-TB) cases.
Ning Rintiswati, Praseno P
doaj  

Home - About - Disclaimer - Privacy